 | ||||||
| mesothelioma clinic | ||||||
| 新闻 | ||||||
| Biotech Analysis Central Pharma News: AbbVie And Roche Stellar Data, Aduro Pulls The Cord ... The reason for doing is so is because of a massive amount of failures in the clinic. Its drug failed to gain traction in mesothelioma and ovarian studies. It posted negative results for those studies. In addition, last year its listeria drug CR-207 combined with GVAX failed to produce any meaningful results in ...
| ||||||
| 查看更多结果 | 修改此快讯 | ||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
 以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment